Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research  How it helps Latest publication
Futalosine
Potential treatment - theoretical effect Natural product Antiviral Jan/08/2021
Tricetin
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Hesperidin
Potential treatment - theoretical effect Natural product Antiviral Oct/27/2020
Gallocatechin gallate
Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020
Euscaphic acid
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Cryptospirolepine
Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020
Theasapogenol B
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Aromadendrin
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Leucopelargonidin
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Arjunic acid
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Shufeng Jiedu
Potential treatment - clinical evidence Natural product Other treatment Oct/22/2020
Shikonin
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/29/2020
Radix Sophorae Tonkinensis
Potential treatment - theoretical effect Natural product Antiviral Feb/22/2020
Rhizoma Polygoni Cuspidati
Potential treatment - theoretical effect Natural product Antiviral Feb/22/2020
Psychotrine
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021